Recursion Pharmaceuticals, Inc. RXRX Materials received not invoiced
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept rxrx:MaterialsReceivedNotInvoiced.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s materials received not invoiced.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s materials received not invoiced?
- Recursion Pharmaceuticals, Inc. (RXRX) reported materials received not invoiced of $1.01M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s materials received not invoiced changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s materials received not invoiced decreased by 38.0% year-over-year, from $1.63M to $1.01M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s materials received not invoiced?
- Over 3 years (2022 to 2025), Recursion Pharmaceuticals, Inc.'s materials received not invoiced has grown at a -29.8% compound annual growth rate (CAGR), from $2.03M to $703K.